Tech Company Financing Transactions

Pulmatrix Funding Round

On 2/22/2013, Pulmatrix raised $3.5 million in funding from private investors.

Transaction Overview

Company Name
Announced On
2/22/2013
Transaction Type
Debt
Amount
$3,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing-amended.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
99 Hayden Ave. 390
Lexington, MA 02421
USA
Email Address
Overview
Pulmatrix Inc. is a pharmaceutical company developing inhalable aerosols and enabling technologies that help control respiratory infectious disease and human-source airborne contamination.
Profile
Pulmatrix LinkedIn Company Profile
Social Media
Pulmatrix Company Twitter Account
Company News
Pulmatrix News
Facebook
Pulmatrix on Facebook
YouTube
Pulmatrix on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ted Raad
  Ted Raad LinkedIn Profile  Ted Raad Twitter Account  Ted Raad News  Ted Raad on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/22/2013: Infochimps venture capital transaction
Next: 2/22/2013: Medikly venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary